title: Gastric carcinoid tumors.
abstract: Initially, carcinoid tumors were a curiosity for physicians and were so named because of their relatively benign behavior as compared to the more common adenocarcinomas. As medicine has evolved, our understanding and management have greatly improved. Our classification system has also become more specific. Gastric carcinoid tumors are unique in that three types have been described based upon each one's pathophysiology. In general, none of these give rise to the typical carcinoid syndrome as seen with metastatic ileal carcinoids.Type 1 gastric carcinoids represent 70% to 80% and are characterized by multiple small lesions and their association with hypergastrinemia secondary to chronic atrophic gastritis and pernicious anemia, and are less likely to metastasize. Type 2 is a rare entity, representing 5%, and is characterized by multiple small lesions, hypergastrinemia secondary to Zollinger-Ellison syndrome, and multiple endocrine neoplasia (MEN) type 1. The risk for metastasis is slightly higher than for type 1; however, overall prognosis is dependent upon the gastrinoma prognosis. Accounting for 20%, type 3 is known as sporadic gastric carcinoids in that there is no association with hypergastrinemia, chronic atrophic gastritis, or Zollinger-Ellison syndrome. These present as large solitary lesions and are often metastatic upon diagnosis. A unique feature of type 3 is its association with an atypical carcinoid syndrome that is thought to be mediated by histamine.The treatment-including medical, endoscopic, and surgical-of gastric carcinoids is dictated by the type, size, and presence of metastasis.
authors: Department of Gastroenterology, Ochsner Clinic Foundation, New Orleans, LA.
authors: Russell
authors: R
authors: Wardlaw
authors: James W
authors: JW
authors: Smith
references: Gastroenterology. 1993 Aug;105(2):579-82
references: 8101501
references: Radiology. 1993 Apr;187(1):129-33
references: 8383865
references: Hematol Oncol Clin North Am. 2007 Jun;21(3):433-55; vii-viii
references: 17548033
references: Gut. 1993 Jan;34(1):28-32
references: 8432447
references: Gastroenterology. 2005 May;128(6):1717-51
references: 15887161
references: Am J Med. 1956 Dec;21(6):867-78
references: 13372563
references: Am J Gastroenterol. 1995 Mar;90(3):338-52
references: 7872269
references: Cancer. 1975 Aug;36(2):560-9
references: 1157019
references: J Clin Oncol. 2005 Jan 1;23(1):70-8
references: 15625361
references: Ann Intern Med. 1996 Jul 1;125(1):26-34
references: 8644985
references: Acta Radiol. 1995 Jul;36(4):367-71
references: 7619613
references: Gastroenterology. 1993 Apr;104(4):994-1006
references: 7681798
references: Ann Surg. 2005 Jul;242(1):64-73
references: 15973103
references: Ann N Y Acad Sci. 2004 Apr;1014:13-27
references: 15153416
references: N Engl J Med. 1990 Nov 1;323(18):1246-9
references: 2170840
references: Exp Clin Endocrinol Diabetes. 1998;106(3):226-30
references: 9710364
references: J Clin Endocrinol Metab. 2001 Feb;86(2):895-902
references: 11158063
references: Lancet. 1963 Feb 2;1(7275):238-9
references: 14000847
references: J Comput Assist Tomogr. 1995 May-Jun;19(3):400-5
references: 7540631
references: Mod Pathol. 1990 Sep;3(5):561-6
references: 2235980
references: Digestion. 1986;35 Suppl 1:42-55
references: 3792671
references: Gastroenterology. 1998 Apr;114(4):817-22
references: 9516403
references: N Engl J Med. 2000 Aug 24;343(8):551-4
references: 10954763
references: Cancer. 2003 Feb 15;97(4):934-59
references: 12569593
references: Pathol Res Pract. 1995 May;191(4):373-80
references: 7479354
references: Gastroenterology. 1999 Jun;116(6):1310-8
references: 10348814
references: Gastroenterology. 2006 Jun;130(7):2217-28
references: 16762644
references: Am J Gastroenterol. 1997 Aug;92(8):1378-80
references: 9260813
references: Gastroenterology. 1992 Apr;102(4 Pt 1):1409-18
references: 1551550
references: Cancer. 2005 Apr 15;103(8):1587-95
references: 15742328
references: Gastroenterology. 1997 Sep;113(3):773-81
references: 9287968